Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$41.12 USD
+0.14 (0.34%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $41.12 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.42 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | -8.33% |
ABR | 1.00 |
Earnings ESP
|
-5.71% |
---|---|
Current Year | -1.75 |
Next Year | -0.67 |
EPS (TTM) | -2.29 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 81.65M | 86.78M | 314.81M | 410.93M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 82.85M | 89.68M | 319.27M | 492.65M |
Low Estimate | 79.50M | 83.26M | 310.30M | 379.89M |
Year ago Sales | 47.73M | 69.55M | 186.37M | 314.81M |
Year over Year Growth Est. | 71.07% | 24.77% | 68.91% | 30.53% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.42 | -0.31 | -1.75 | -0.67 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.41 | -0.38 | -2.07 | 0.43 |
High Estimate | -0.30 | 0.08 | -0.81 | 1.45 |
Low Estimate | -0.53 | -0.50 | -2.27 | -2.02 |
Year ago EPS | -0.57 | -0.66 | -3.94 | -1.75 |
Year over Year Growth Est. | 26.32% | 53.03% | 55.58% | 61.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 4 | 5 | 4 |
Down Last 60 Days | 4 | 4 | 5 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.42 | -0.31 | -1.75 | -0.67 |
7 Days Ago | -0.42 | -0.31 | -1.75 | -0.67 |
30 Days Ago | -0.37 | -0.27 | -1.66 | -0.45 |
60 Days Ago | -0.37 | -0.27 | -1.66 | -0.45 |
90 Days Ago | -0.27 | -0.10 | -1.39 | 0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.29 | -1.82 | -0.67 |
Zacks Consensus Estimate | -0.42 | -0.31 | -1.75 | -0.67 |
Earnings ESP | -5.71% | 5.30% | -4.36% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.54 | -0.66 | -0.57 | NA |
Estimate | -0.48 | -0.40 | -0.34 | -0.64 | NA |
Difference | -0.04 | -0.14 | -0.32 | 0.07 | -0.11 |
Surprise | -8.33% | -35.00% | -94.12% | 10.94% | -31.63% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more